Matches in Wikidata for { <http://www.wikidata.org/entity/Q61936793> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q61936793 description "assaig clínic" @default.
- Q61936793 description "clinical trial" @default.
- Q61936793 description "clinical trial" @default.
- Q61936793 description "clinical trial" @default.
- Q61936793 description "clinical trial" @default.
- Q61936793 description "ensaio clínico" @default.
- Q61936793 description "ensayo clínico" @default.
- Q61936793 description "ensayu clínicu" @default.
- Q61936793 description "essai clinique" @default.
- Q61936793 description "klinisch onderzoek" @default.
- Q61936793 description "клінічне випробування" @default.
- Q61936793 description "կլինիկական փորձարկում" @default.
- Q61936793 name "A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen" @default.
- Q61936793 type Item @default.
- Q61936793 label "A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen" @default.
- Q61936793 prefLabel "A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen" @default.
- Q61936793 P1050 Q61936793-13E4787B-8E89-4748-AA5D-E05A09D637D3 @default.
- Q61936793 P1132 Q61936793-1C55BC22-BD57-49D1-B85C-9F5451D62C8B @default.
- Q61936793 P1476 Q61936793-0D706B1D-5156-4A85-9C93-A58A2D48F9F2 @default.
- Q61936793 P17 Q61936793-C113EAEC-26FC-4411-9C39-FBC4DEA06FAF @default.
- Q61936793 P2899 Q61936793-24B8A1B2-3063-474E-9050-BFBDFA6FA3E9 @default.
- Q61936793 P3098 Q61936793-FF69479B-8564-4011-900E-8769FD95E1A7 @default.
- Q61936793 P31 Q61936793-EB9A6D49-5C12-423E-8291-A735539ACF9C @default.
- Q61936793 P4844 Q61936793-15F2D0E9-B22B-49CE-BF77-50B76DDEC8F2 @default.
- Q61936793 P580 Q61936793-032CB84C-1F2D-46F9-A3CC-52CA605AF8E1 @default.
- Q61936793 P582 Q61936793-4B67ED11-4349-40F3-97BC-76530E18C187 @default.
- Q61936793 P6099 Q61936793-189B61B0-9335-41B0-9131-06D8DA7F4853 @default.
- Q61936793 P8363 Q61936793-0F5711DC-8F1D-4FC6-A0F7-AC6C66C56B33 @default.
- Q61936793 P1050 Q356033 @default.
- Q61936793 P1132 "+41" @default.
- Q61936793 P1476 "A Phase 1 Study of MLN8237, an Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen" @default.
- Q61936793 P17 Q30 @default.
- Q61936793 P2899 "+18" @default.
- Q61936793 P3098 "NCT01094288" @default.
- Q61936793 P31 Q30612 @default.
- Q61936793 P4844 Q420436 @default.
- Q61936793 P580 "2010-08-17T00:00:00Z" @default.
- Q61936793 P582 "2014-02-28T00:00:00Z" @default.
- Q61936793 P6099 Q5452194 @default.
- Q61936793 P8363 Q78089383 @default.